Nora Henrikson (she/her) is an associate investigator at Kaiser Permanente Washington Health Research Institute. She leads a research portfolio focused on interventions to improve cancer care delivery, health equity, and patient outcomes.
Her current research explores methods for improving risk notification and cascading genetic testing for family members of people with hereditary cancers as well as interventions to mitigate cancer-related financial hardship. Dr. Henrikson also leads systematic evidence reviews on cancer screening and behavioral counseling with the Kaiser Permanente Evidence-based Practice Center.
Dr. Henrikson holds affiliate faculty appointments at the University of Washington School of Public Health in the Department of Health Systems and Population Health, and the Institute for Public Health Genetics. She is also an associate professor at the Bernard J. Tyson Kaiser Permanente School of Medicine.
She has a PhD from the University of Washington School of Public Health’s Institute for Public Health Genetics, an MPH from the University of North Carolina at Chapel Hill, and a BA (sociology) from Lehigh University.
Genetic testing for cancer risk, cancer-related financial hardship
Financial hardship, health equity
Quantitative, qualitative, and mixed methods; intervention design; implementation science
Systematic review and evidence synthesis; epidemiology
Social, ethical, and policy implications of genomics and precision health
White LL, Sawyer JK, Zepp JM, Prado YK, Reyes AA, Maiyani M, Shuster E, Zucker R, Henrikson NB, Rope AF, Weinmann S, Feigelson HS, Ezzell Hunter J. Genetic testing uptake among ovarian cancer survivors in the Genetic Risk Analysis in Ovarian Cancer (GRACE) study. Cancers (Basel). 2024;16(14):2563. doi: 10.3390/cancers16142563. PubMed
Figueroa Gray M, Randall S, Banegas M, Ryan GW, Henrikson NB. Personal legacy and treatment choices for serious illness: A scoping review. BMJ Support Palliat Care. 2024 Jan 24:spcare-2023-004439. doi: 10.1136/spcare-2023-004439. [Epub ahead of print]. PubMed
Henrikson NB, Ivlev I, Blasi PR, Nguyen MB, Senger CA, Perdue LA, Lin JS. Skin cancer screening: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2023 Apr 18;329(15):1296-1307. doi: 10.1001/jama.2023.3262. PubMed
Reddy A, Maynard C, Kaboli P, Rinne ST, Henrikson NB, Nelson KM, Liu CF, Sterling R, Wong E. Identifying individual and clinic characteristics associated with primary care provider turnover during implementation of the Veterans Health Administration Patient-Centered Medical Home. J Ambul Care Manage. 2023 Jul-Sep;46(3):221-227. doi: 10.1097/JAC.0000000000000469. Epub 2023 Apr 7. PubMed
Grabert BK, McRee AL, Henrikson NB, Heisler-MacKinnon J, Blasi PR, Norris CM, Nguyen MB, Dunn J, McKeithen MC, Gilkey MB. Feasibility of using an app-based coaching intervention to improve provider communication about HPV vaccination. Transl Behav Med. 2023 Aug 11;13(8):581-588. doi: 10.1093/tbm/ibad002. PubMed
Martucci J, Prado Y, Rope AF, Weinmann S, White L, Zepp J, Henrikson NB, Feigelson HS, Hunter JE, Lee SS. An examination of the ethical and legal limits in implementing "traceback testing" for deceased patients. J Law Med Ethics. 2022;50(4):818-832. doi: 10.1017/jme.2023.23. PubMed
Henderson JT, Martin A, Patnode CD, Henrikson NB. A synthesis of qualitative studies on patient and caregiver experiences with cognitive impairment screening and diagnosis. Aging Ment Health. 2022 Oct 3:1-12. doi: 10.1080/13607863.2022.2126431. [Epub ahead of print]. PubMed
Blasi PR, Scrol A, Anderson ML, Gray MF, Tiffany B, Fullerton SM, Ralston JD, Leppig KA, Henrikson NB. Feasibility, acceptability, and limited efficacy of health system-led familial risk notification: protocol for a mixed-methods evaluation. Pilot Feasibility Stud. 2022 Aug 9;8(1):174. doi: 10.1186/s40814-022-01142-9. PubMed
Henrikson NB, Anderson ML, Dickerson J, Ewing JJ, Garcia R, Keast E, King DA, Lewis C, Locher B, McMullen C, Norris CM, Petrik AF, Ramaprasan A, Rivelli JS, Schneider JL, Shulman L, Tuzzio L, Banegas MP. The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship. Trials. 2022 May 13;;23(1):402. doi: 10.1186/s13063-022-06344-3. PubMed
Leppig KA, Rahm AK, Appelbaum P, Aufox S, Bland ST, Buchanan A, Christensen KD, Chung WK, Wright-Clayton E, Crosslin D, Denny J, DeVange S, Gordon A, Green RC, Hakonarson H, Harr MH, Henrikson NB, Hoell C, Holm IA, Kullo IJ, Jarvik GP, Lammers PE, Larson EB, Lindor NM, Marasa M, Myer MF, Perez E, Peterson JF, Pratap S, Prows CA, Ralston JD, Rasouly HM, Roden DM, Sharp RR, Singh R, Shaibi G, Smith ME, Sturm A, Thiese HA, Van Driest SL, Williams J, Williams MS, Wynn J, Zawatsky CL, Weisner GL. The reckoning: the return of genomic results to 1444 participants across the eMERGE3 Network. Genet Med. 2022 May;24(5):1130-1138. doi: 10.1016/j.gim.2022.01.015. Epub 2022 Feb 23. PubMed
KPWHRI researchers answer questions about systematic reviews and their impact on health care guidelines.
The HCSRN conference is a venue for collaborative work to improve health and health care.
Dr. Henrikson’s Annals of Internal Medicine study describes 3 kinds of cost concerns that can affect cancer care.
Nora Henrikson discusses her latest research published in the Annals of Internal Medicine in May 2019. (Vimeo, 3:50)